250 lines (249 with data), 8.4 kB
T1 Age 2 13 51-year-old
T2 Sex 14 17 man
T3 Clinical_event 22 30 referred
E1 Clinical_event:T3
T4 Biological_structure 38 46 hospital
R1 MODIFY Arg1:T4 Arg2:E1
T5 Severity 54 60 severe
T6 Disease_disorder 72 85 heart failure
E2 Disease_disorder:T6
T7 Detailed_description 61 71 congestive
R2 MODIFY Arg1:T7 Arg2:E2
R3 MODIFY Arg1:T5 Arg2:E2
T8 Disease_disorder 102 113 arrhythmias
E3 Disease_disorder:T8
T9 Biological_structure 90 101 ventricular
R4 MODIFY Arg1:T9 Arg2:E3
T10 Date 117 127 March 2008
E4 Date:T10
T11 Disease_disorder 156 169 heart failure
E5 Disease_disorder:T11
T12 Sign_symptom 186 197 tachycardia
E6 Sign_symptom:T12
T13 Biological_structure 174 185 ventricular
R5 MODIFY Arg1:T13 Arg2:E6
T14 Duration 198 207 for years
E7 Duration:T14
T15 Therapeutic_procedure 230 252 conventional treatment
E8 Therapeutic_procedure:T15
T16 Medication 258 268 furosemide
E9 Medication:T16
T17 Medication 270 288 lisinopril hydrate
E10 Medication:T17
T18 Medication 290 300 pimobendan
E11 Medication:T18
T19 Medication 302 320 warfarin potassium
E12 Medication:T19
T20 Medication 322 332 carvedilol
E13 Medication:T20
T21 Medication 334 346 metildigoxin
E14 Medication:T21
T22 Medication 351 375 amiodarone hydrochloride
E15 Medication:T22
R6 SUB_PROCEDURE Arg1:E9 Arg2:E8
R7 SUB_PROCEDURE Arg1:E10 Arg2:E8
R8 SUB_PROCEDURE Arg1:E11 Arg2:E8
R9 SUB_PROCEDURE Arg1:E12 Arg2:E8
R10 SUB_PROCEDURE Arg1:E13 Arg2:E8
R11 SUB_PROCEDURE Arg1:E14 Arg2:E8
R12 SUB_PROCEDURE Arg1:E15 Arg2:E8
T23 Height 393 399 161 cm
T24 Weight 420 425 83 kg
T25 Diagnostic_procedure 427 441 Blood pressure
E16 Diagnostic_procedure:T25
T26 Lab_value 446 458 110/60 mm Hg
R13 MODIFY Arg1:T26 Arg2:E16
T27 Diagnostic_procedure 464 485 fasting blood glucose
E17 Diagnostic_procedure:T27
T28 Lab_value 490 499 107 mg/dl
R14 MODIFY Arg1:T28 Arg2:E17
T29 Diagnostic_procedure 504 509 HbA1c
E18 Diagnostic_procedure:T29
T30 Lab_value 514 518 6.3%
R15 MODIFY Arg1:T30 Arg2:E18
T31 Diagnostic_procedure 530 535 x-ray
E19 Diagnostic_procedure:T31
T32 Biological_structure 524 529 chest
R16 MODIFY Arg1:T32 Arg2:E19
T33 Sign_symptom 543 555 cardiomegaly
E20 Sign_symptom:T33
T34 Diagnostic_procedure 563 583 cardiothoracic ratio
E21 Diagnostic_procedure:T34
T35 Lab_value 587 591 0.67
R17 MODIFY Arg1:T35 Arg2:E21
T36 Diagnostic_procedure 605 608 ECG
E22 Diagnostic_procedure:T36
T37 Sign_symptom 651 677 hypokinetic left ventricle
E23 Sign_symptom:T37
T38 Detailed_description 642 650 diffused
R18 MODIFY Arg1:T38 Arg2:E23
T39 Diagnostic_procedure 700 724 left ventricle dimension
E24 Diagnostic_procedure:T39
T41 Diagnostic_procedure 726 738 end-diastole
E25 Diagnostic_procedure:T41
T42 Lab_value 740 745 95 mm
R20 MODIFY Arg1:T42 Arg2:E25
T43 Diagnostic_procedure 759 761 EF
E26 Diagnostic_procedure:T43
T44 Lab_value 763 767 0.11
R21 MODIFY Arg1:T44 Arg2:E26
#1 AnnotatorNotes E26 ejection fraction
T45 Lab_value 751 758 reduced
R22 MODIFY Arg1:T45 Arg2:E26
T46 Diagnostic_procedure 783 792 angiogram
E27 Diagnostic_procedure:T46
T47 Biological_structure 774 782 coronary
R23 MODIFY Arg1:T47 Arg2:E27
T48 Lab_value 797 803 normal
R24 MODIFY Arg1:T48 Arg2:E27
T49 Diagnostic_procedure 818 824 biopsy
E28 Diagnostic_procedure:T49
T50 Biological_structure 807 817 myocardial
R25 MODIFY Arg1:T50 Arg2:E28
T51 Sign_symptom 1002 1021 thickening of hands
E29 Sign_symptom:T51
T52 Nonbiological_location 1046 1070 endocrinology department
T53 Clinical_event 1030 1038 referred
E30 Clinical_event:T53
T54 Diagnostic_procedure 1076 1094 plasma level of GH
E31 Diagnostic_procedure:T54
T55 Diagnostic_procedure 1113 1118 IGF-1
E32 Diagnostic_procedure:T55
T56 Lab_value 1099 1108 8.2 ng/ml
R26 MODIFY Arg1:T56 Arg2:E31
T57 Lab_value 1123 1132 504 ng/ml
R27 MODIFY Arg1:T57 Arg2:E32
T58 Diagnostic_procedure 1134 1137 MRI
E33 Diagnostic_procedure:T58
T59 Disease_disorder 1153 1165 macroadenoma
E34 Disease_disorder:T59
T60 Biological_structure 1173 1182 pituitary
R28 MODIFY Arg1:T60 Arg2:E34
T61 Therapeutic_procedure 919 945 cardioverter-defibrillator
E35 Therapeutic_procedure:T61
T62 Detailed_description 907 918 implantable
R29 MODIFY Arg1:T62 Arg2:E35
T63 Sign_symptom 883 891 fibrosis
E36 Sign_symptom:T63
T64 Lab_value 839 865 over 50% of cardiomyocytes
R30 MODIFY Arg1:T64 Arg2:E36
T65 Diagnostic_procedure 980 997 facial appearance
E37 Diagnostic_procedure:T65
T66 Lab_value 972 979 typical
R31 MODIFY Arg1:T66 Arg2:E37
T67 Disease_disorder 1210 1220 acromegaly
E38 Disease_disorder:T67
T68 Medication 1242 1252 octreotide
E39 Medication:T68
T69 Duration 1283 1291 8 months
E40 Duration:T69
T70 Detailed_description 1253 1272 long-acting-release
T71 Detailed_description 1274 1277 LAR
R32 IDENTICAL Arg1:T71 Arg2:T70
R33 MODIFY Arg1:T70 Arg2:E39
T72 Therapeutic_procedure 1318 1342 trans-sphenoidal surgery
E41 Therapeutic_procedure:T72
T73 Date 1346 1358 January 2009
E42 Date:T73
T74 Medication 2066 2076 pimobendan
E43 Medication:T74
T75 Diagnostic_procedure 1375 1394 plasma levels of GH
E44 Diagnostic_procedure:T75
T76 Diagnostic_procedure 1399 1404 IGF-1
E45 Diagnostic_procedure:T76
T77 Lab_value 1410 1419 decreased
R34 MODIFY Arg1:T77 Arg2:E45
R35 MODIFY Arg1:T77 Arg2:E44
T78 Medication 1425 1435 octreotide
E46 Medication:T78
T79 Diagnostic_procedure 1445 1470 basal plasma levels of GH
E47 Diagnostic_procedure:T79
T80 Lab_value 1483 1500 more than 4 ng/ml
R36 MODIFY Arg1:T80 Arg2:E47
T81 Diagnostic_procedure 1505 1524 plasma IGF-1 levels
E48 Diagnostic_procedure:T81
T82 Lab_value 1530 1561 above the appropriate age range
R37 MODIFY Arg1:T82 Arg2:E48
T83 Coreference 1580 1587 surgery
E49 Coreference:T83
R38 IDENTICAL Arg1:E49 Arg2:E41
T84 Diagnostic_procedure 1594 1613 plasma levels of GH
E50 Diagnostic_procedure:T84
T85 Diagnostic_procedure 1618 1623 IGF-1
E51 Diagnostic_procedure:T85
T86 Lab_value 1624 1641 further decreased
R39 MODIFY Arg1:T86 Arg2:E51
R40 MODIFY Arg1:T86 Arg2:E50
T87 Diagnostic_procedure 1643 1668 Basal plasma levels of GH
E52 Diagnostic_procedure:T87
T88 Lab_value 1674 1700 mostly less than 0.5 ng/ml
R41 MODIFY Arg1:T88 Arg2:E52
T89 Diagnostic_procedure 1705 1710 IGF-1
E53 Diagnostic_procedure:T89
T90 Lab_value 1723 1743 within normal ranges
R42 MODIFY Arg1:T90 Arg2:E53
T91 Coreference 1778 1781 LAR
E54 Coreference:T91
R43 IDENTICAL Arg1:E54 Arg2:E46
T92 Detailed_description 1436 1439 LAR
R44 MODIFY Arg1:T92 Arg2:E46
T93 Diagnostic_procedure 1787 1803 cardiac function
E55 Diagnostic_procedure:T93
T94 Lab_value 1804 1822 improved partially
R45 MODIFY Arg1:T94 Arg2:E55
T95 Diagnostic_procedure 1824 1844 cardiothoracic ratio
E56 Diagnostic_procedure:T95
T96 Lab_value 1845 1849 0.58
R46 MODIFY Arg1:T96 Arg2:E56
T97 Diagnostic_procedure 1851 1853 EF
E57 Diagnostic_procedure:T97
T98 Lab_value 1854 1858 0.20
R47 MODIFY Arg1:T98 Arg2:E57
T99 Date 1862 1876 September 2008
E58 Date:T99
T100 Coreference 1885 1892 surgery
E59 Coreference:T100
R48 IDENTICAL Arg1:E59 Arg2:E49
T101 Diagnostic_procedure 1898 1914 cardiac function
E60 Diagnostic_procedure:T101
T102 Lab_value 1915 1935 improved drastically
R49 MODIFY Arg1:T102 Arg2:E60
T103 Diagnostic_procedure 1937 1957 cardiothoracic ratio
E61 Diagnostic_procedure:T103
T104 Lab_value 1958 1962 0.47
R50 MODIFY Arg1:T104 Arg2:E61
T105 Diagnostic_procedure 1964 1966 EF
E62 Diagnostic_procedure:T105
T106 Lab_value 1967 1971 0.55
R51 MODIFY Arg1:T106 Arg2:E62
T107 Date 1975 1985 April 2009
E63 Date:T107
T108 Disease_disorder 2040 2051 arrhythmias
E64 Disease_disorder:T108
T109 Biological_structure 2028 2039 ventricular
R52 MODIFY Arg1:T109 Arg2:E64
T110 Lab_value 2015 2024;2052 2061 Frequency decreased
A1 TREND E43 DEC
* OVERLAP E1 E2 E3 E4
R53 AFTER Arg1:E4 Arg2:E5
* OVERLAP E5 E6 E7 E8
R54 BEFORE Arg1:E8 Arg2:E16
* OVERLAP E16 E17 E18 E19 E20 E21 E22 E23 E24 E25 E26 E27 E28 E36
T40 Lab_value 683 699 markedly dilated
R19 MODIFY Arg1:T40 Arg2:E24
R55 BEFORE Arg1:E36 Arg2:E35
* OVERLAP E35 E37 E29
R56 BEFORE Arg1:E29 Arg2:E30
R57 MODIFY Arg1:T52 Arg2:E30
* OVERLAP E30 E31 E32 E33 E34 E38
R58 BEFORE Arg1:E38 Arg2:E39
* OVERLAP E39 E40
R59 BEFORE Arg1:E40 Arg2:E41
* OVERLAP E41 E42
R60 AFTER Arg1:E42 Arg2:E44
* OVERLAP E44 E45 E46 E47 E48
R61 BEFORE Arg1:E48 Arg2:E49
R62 BEFORE Arg1:E49 Arg2:E50
* OVERLAP E50 E51 E52 E53 E54 E55 E56 E57 E58
R63 BEFORE Arg1:E58 Arg2:E59
* OVERLAP E59 E60 E61 E62 E63 E64 E43